Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level

被引：0

作者：

Evelien M Bunnik

Zelda Euler

Matthijs R A Welkers

Brigitte D M Boeser-Nunnink

Marlous L Grijsen

Jan M Prins

Hanneke Schuitemaker

机构：

[1] Sanquin Research,Department of Experimental Immunology

[2] Landsteiner Laboratory,Department of Infectious Diseases

[3] Center for Infection and Immunity Amsterdam,undefined

[4] Academic Medical Center,undefined

[5] University of Amsterdam,undefined

[6] Tropical Medicine and AIDS,undefined

[7] Center for Infection and Immunity Amsterdam,undefined

[8] Academic Medical Center,undefined

[9] University of Amsterdam,undefined

[10] Present addresses: Department of Medical Microbiology,undefined

[11] Center for Infection and Immunity Amsterdam,undefined

[12] Academic Medical Center,undefined

[13] University of Amsterdam,undefined

[14] Amsterdam,undefined

[15] The Netherlands (M.R.A.W.) and Crucell Holland BV,undefined

[16] Leiden,undefined

[17] The Netherlands (H.S.).,undefined

来源：

Nature Medicine | 2010年 / 16卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The rapid mutation rate of HIV-1 enables its escape from neutralizing antibodies (NAbs) in infected individuals. Bunnik et al. now show that the immune pressure exerted by NAbs has, over the course of the HIV epidemic, altered the HIV-1 envelope glycoprotein such that HIV-1 variants isolated from recently infected individuals are more resistant to NAbs, compared with viral variants isolated from individuals infected at the start of the epidemic. Their results suggest the need to carefully select the envelope gene used in today's vaccine efforts.

引用

页码：995 / 997

页数：2

共 50 条

[21] MORPHOMETRIC ANALYSIS OF ENVELOPE GLYCOPROTEIN GP120 DISTRIBUTION ON HIV-1 VIRIONS
HART, TK
KLINKNER, AM
VENTRE, J
BUGELSKI, PJ
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1993, 41 (02) : 265 - 271
[22] Structural requirements of glycosaminoglycans for their interaction with HIV-1 envelope glycoprotein gp120
Matos, Pedro M.
Andreu, David
Santos, Nuno C.
Gutierrez-Gallego, Ricardo
ARCHIVES OF VIROLOGY, 2014, 159 (03) : 555 - 560
[23] Effects of an HIV-1 attachment inhibitor on the conformation of the viral envelope Gp120
Ho, HT
Fan, L
Dicker, I
McAuliffe, B
Zhou, NN
Fridell, R
Robinson, J
Colonno, R
Lin, PF
ANTIVIRAL RESEARCH, 2004, 62 (02) : A53 - A53
[24] TOWARDS A STRUCTURE OF THE HIV-1 ENVELOPE GLYCOPROTEIN GP120 - AN IMMUNOCHEMICAL APPROACH
MOORE, JP
JAMESON, BA
SATTENTAU, QJ
WILLEY, R
SODROSKI, J
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1993, 342 (1299) : 83 - 88
[25] HIV-1 ENVELOPE GP120 ALTERS ASTROCYTES IN HUMAN BRAIN CULTURES
PULLIAM, L
WEST, D
HAIGWOOD, N
SWANSON, RA
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (05) : 439 - 444
[26] Structural requirements of glycosaminoglycans for their interaction with HIV-1 envelope glycoprotein gp120
Pedro M. Matos
David Andreu
Nuno C. Santos
Ricardo Gutiérrez-Gallego
Archives of Virology, 2014, 159 : 555 - 560
[27] Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41
Huang, L
Zhang, L
Chen, CH
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (18) : 1453 - 1462
[28] P04-49 LB. Adaptation of HIV-1 envelope glycoprotein to humoral immunity at a population level
EM Bunnik
Z Euler
M Welkers
M Grijsen
J Prins
H Schuitemaker
Retrovirology, 6
[29] Optimizing cellular immunity against HIV-1 Gag and preventing suppression by HIV-1 gp120
van Montfort, Thijs
Sanders, Rogier W.
EXPERT REVIEW OF VACCINES, 2012, 11 (10) : 1175 - 1177
[30] HIV-1 gp120 and immune network
Metlas, R
Veljkovic, V
INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2004, 23 (5-6) : 413 - 422

← 1 2 3 4 5 →